Integration and application of new approach methodologies in assessing the developmental hazards: Case study with an antimalarial drug

Birth Defects Res. 2023 Jul 1;115(12):1105-1108. doi: 10.1002/bdr2.2190. Epub 2023 May 23.

Authors

Claudia Demarta-Gatsi¹, Amer Jamalpoor², Giel Hendriks², Belen Tornesi¹

Affiliations

¹ Medicines for Malaria Venture (MMV), Geneva, Switzerland.
² Toxys B.V, Leiden Bio Science Park, The Netherlands.

PMID: 37219047
DOI: 10.1002/bdr2.2190

No abstract available

Publication types

Editorial

MeSH terms

Antimalarials* / adverse effects

Substances

Antimalarials